Generation of high-avidity, WT1-reactive CD8+cytotoxic T cell clones with anti-leukemic activity by streptamer technology

Antje Tunger; Rebekka Wehner; Malte von Bonin; Denise Kühn; Falk Heidenreich; Sarah Matko; Magdalena Nauerth; Elke Ruecker-Braun; Sevina Dietz; Cornelia S. Link; Anne Eugster; Marcus Odendahl; Dirk H. Busch; Torsten Tonn; Ezio Bonifacio; Lothar Germeroth; Johannes Schetelig; Michael P. Bachmann; Martin Bornhaeuser; Marc Schmitz

doi:10.1080/10428194.2016.1233538

Generation of high-avidity, WT1-reactive CD8+cytotoxic T cell clones with anti-leukemic activity by streptamer technology

Research output: Contribution to journal › Letter › Contributed › peer-review

Contributors

Antje Tunger - , Institute for Immunology (Author)
Rebekka Wehner - , Institute for Immunology, National Center for Tumor Diseases Dresden (Author)
Malte von Bonin - , Department of Internal Medicine I, National Center for Tumor Diseases Dresden, German Cancer Consortium (DKTK) Partner Site Dresden, German Cancer Research Center (DKFZ) (Author)
Denise Kühn - , TUD Dresden University of Technology (Author)
Falk Heidenreich - , Department of Internal Medicine I (Author)
Sarah Matko - , DRK Blutspendendienst Nord Ost gGmbH (Author)
Magdalena Nauerth - , Technical University of Munich (Author)
Elke Ruecker-Braun - , Department of Internal Medicine I (Author)
Sevina Dietz - , TUD Dresden University of Technology (Author)
Cornelia S. Link - , Department of Internal Medicine I, Center for Regenerative Therapies Dresden (Author)
Anne Eugster - , Chair of Preclinical stem cell therapy and diabetes (Author)
Marcus Odendahl - , DRK Blutspendendienst Nord Ost gGmbH (Author)
Dirk H. Busch - , Technical University of Munich (Author)
Torsten Tonn - , Center for Regenerative Therapies Dresden, German Cancer Consortium (DKTK) Partner Site Dresden, German Cancer Research Center (DKFZ), DRK Blutspendendienst Nord Ost gGmbH (Author)
Ezio Bonifacio - , Chair of Preclinical stem cell therapy and diabetes (Author)
Lothar Germeroth - (Author)
Johannes Schetelig - , Department of Internal Medicine I (Author)
Michael P. Bachmann - , National Center for Tumor Diseases Dresden, Center for Regenerative Therapies Dresden, German Cancer Consortium (DKTK) Partner Site Dresden, German Cancer Research Center (DKFZ), Helmholtz-Zentrum Dresden-Rossendorf (Author)
Martin Bornhaeuser - , Department of Internal Medicine I, National Center for Tumor Diseases Dresden, Center for Regenerative Therapies Dresden, German Cancer Research Center (DKFZ) (Author)
Marc Schmitz - , Institute for Immunology, National Center for Tumor Diseases Dresden, Center for Regenerative Therapies Dresden, German Cancer Research Center (DKFZ) (Author)

Details

Original language	English
Pages (from-to)	1246-1249
Number of pages	4
Journal	Leukemia and lymphoma
Volume	58
Issue number	5
Publication status	Published - 2017
Peer-reviewed	Yes

External IDs

WOS	000393894000033
researchoutputwizard	legacy.publication#78653
researchoutputwizard	legacy.publication#78316
Scopus	84995561954
researchoutputwizard	legacy.publication#79598
ORCID	/0000-0002-8704-4713/work/141544097

Research Portal of the TU Dresden

Generation of high-avidity, WT1-reactive CD8+cytotoxic T cell clones with anti-leukemic activity by streptamer technology

Contributors

Details

External IDs

Keywords

Research priority areas of TU Dresden

DFG Classification of Subject Areas according to Review Boards